Continuation versus Interruption of Oral Anticoagulation during TAVI
DJ van Ginkel, WL Bor, HM Aarts… - … England Journal of …, 2024 - Mass Medical Soc
Background One third of patients undergoing transcatheter aortic-valve implantation (TAVI)
have an indication for oral anticoagulation owing to concomitant diseases. Interruption of …
have an indication for oral anticoagulation owing to concomitant diseases. Interruption of …
Predicting major adverse events in patients undergoing transcatheter left atrial appendage occlusion
KF Faridi, EL Ong, S Zimmerman… - Circulation …, 2024 - Am Heart Assoc
BACKGROUND: The National Cardiovascular Data Registry Left Atrial Appendage
Occlusion Registry (LAAO) includes the vast majority of transcatheter LAAO procedures …
Occlusion Registry (LAAO) includes the vast majority of transcatheter LAAO procedures …
Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices
S Sorrentino, A Di Costanzo, N Salerno… - Current Vascular …, 2024 - ingentaconnect.com
Large bore accesses refer to accesses with a diameter of 10 French or greater and are
necessary for various medical devices, including those used in transcatheter aortic valve …
necessary for various medical devices, including those used in transcatheter aortic valve …
Review of Bleeding and Thrombotic Risks Associated With Antithrombotic Therapy After Transcatheter Structural Heart Interventions
H Kawashima, Y Numasawa, N Hayakawa, T Asano… - JACC: Asia, 2024 - jacc.org
Transcatheter structural heart interventions have drastically evolved over the past 2
decades. However, most catheterization procedures require the deployment of devices in …
decades. However, most catheterization procedures require the deployment of devices in …
Comparison of direct oral anticoagulants vs vitamin K antagonists after transcatheter mitral valve replacement
N El Bèze, D Himbert, G Suc, E Brochet… - Journal of the American …, 2024 - jacc.org
Background There is currently no established recommendation for antithrombotic treatment
following transcatheter mitral valve replacement (TMVR). However, based on the analogy …
following transcatheter mitral valve replacement (TMVR). However, based on the analogy …
[HTML][HTML] Comparison of clinical and echocardiographic outcomes between mini-thoracotomy transatrial LuX-Valve transcatheter and surgical tricuspid valve …
L Huang, Z Sun, Y Cai, Y Xie, Z Zhang… - Frontiers in …, 2024 - frontiersin.org
Background and aims Transcatheter tricuspid valve replacement (TTVR) has recently
emerged as a novel therapeutic approach for managing severe tricuspid regurgitation (TR) …
emerged as a novel therapeutic approach for managing severe tricuspid regurgitation (TR) …
Late bleeding events in TAVI patients receiving vitamin K antagonists or direct oral anticoagulants
A Alperi, R Ptaszynski, I Pascual, R Del Valle… - Revista Española de …, 2024 - Elsevier
Introduction and objectives The optimal chronic antithrombotic regimen for patients with
atrial fibrillation undergoing transcatheter aortic valve implantation (TAVI) remains uncertain …
atrial fibrillation undergoing transcatheter aortic valve implantation (TAVI) remains uncertain …
Feasibility of a modified hybrid glubran-supported single-proglide technique for access closure during endovascular aneurysm repair
C Xu, G Xu, L Chen, Z Zhang, Y Jin - Frontiers in Cardiovascular …, 2024 - frontiersin.org
Objective This study aimed to evaluate the feasibility of a hybrid Glubran-supported single-
Proglide technique for large bore femoral access closure during percutaneous access …
Proglide technique for large bore femoral access closure during percutaneous access …
[HTML][HTML] Red Blood Cell Transfusion Strategies in Cardiovascular Interventions
M Foglietta, E Bacigalupi, F Radico… - Reviews in …, 2024 - ncbi.nlm.nih.gov
Acute coronary syndrome, cardiac surgery, and cardiac structural interventions are among
the most common situations leading to allogeneic red blood cell consumption due to the …
the most common situations leading to allogeneic red blood cell consumption due to the …
[HTML][HTML] Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document
P Garot, MC Morice, DJ Angiolillo… - … of EuroPCR in …, 2024 - eurointervention.pcronline.com
The identification and management of patients at high bleeding risk (HBR) undergoing
transcatheter aortic valve implantation (TAVI) are of major importance, but the lack of …
transcatheter aortic valve implantation (TAVI) are of major importance, but the lack of …